Subject
Cardiology and Cardiovascular Medicine
Reference10 articles.
1. Three-year follow-up of treatment-naïve and previously treated patients with CLL and SLL receiving single-agent ibrutinib;Byrd;Blood,2015
2. Cardiovascular side effects of tyrosine kinase inhibitor ibrutinib (imbruvica) and interaction with direct oral anticoagulant;Khalid;Am J Ther,2018
3. Ibrutinib-associated cardiac tamponade with concurrent antiplatelet therapy;Miatech;Case Rep Hematol,2020
4. Hemorrhagic pericardial effusion an unreported complication of ibrutinib;Patel;Am J Respir Crit Care Med,2019
5. Acute haemorrhagic tamponade in cancer patients receiving direct oral anticoagulant: case series;Nassif;Eur Heart J Case Rep,2017
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Apixaban/ibrutinib;Reactions Weekly;2023-07-15